Föreläsningar och seminarier Pedatric Oncology weekly seminar
With Diana Tries and Jakob Stenman
Diana Tries, PhD student (MD), Kogner lab
Title: Novel therapeutic combinations for neuroblastoma – Exploring synergistic effects Wip1 inhibitors and epigenetic modifiers.
Summary: Synergy between SL-176, an inhibitor of neuroblastoma therapeutic target Wip1, and the H3K27 demethylase inhibitor GSK-J4 was detected in drug combination screening and confirmed on protein level.
Jakob Stenman, Pediatric surgeon, Group leader (MD, PhD), BCFE
Title: Lutetium-DOTATATE-neuroblastoma (LuiDO-N) study updates
Summary: A new clinical study using Lutetium-177 DOTATATE as a targeted treatment strategy against high-risk relapsed neuroblastoma
Moderator: Nikolas Herold, Assistant professor (MD, PhD), BCFE